Home
About Us
About NDC
Meet Our Team
Services
Ultrasound
X-Ray
CT Scan
Pathlab
Nuclear Medicine
Health Packages
Lifestyle
Health Packages
Contact Us
Feedback
Menu
Home
/
Nuclear Medicine
/
Radionucleide Therapy
/ 177 Lu – Lutetium PSMA therapy for metastatic castrate resistant prostate cancer
Product categories
Condition
(136)
Cancer
(43)
CKD
(37)
Diabetes
(25)
Infertility
(26)
Jaundice
(31)
Joint Pain
(18)
Pregnancy
(32)
Health Packages
(10)
Lifestyle
(42)
Alcoholism
(17)
Nutrition Related
(20)
Obesity
(10)
Sleeplessness
(5)
Smoking
(13)
Nuclear Medicine
(42)
Gamma Camera Scans
(26)
PET CT
(4)
18 F-FDG PET-CT
(3)
Radionucleide Therapy
(12)
Organ
(95)
Blood
(6)
Bones
(18)
Chest
(21)
Digestive System
(2)
ENT
(19)
Eyes
(11)
Heart
(21)
Hormone
(10)
Kidney
(2)
Liver
(2)
Prostate
(4)
Reproductive System
(29)
Thyroid
(8)
Pathlab
(143)
Biochemistry
(43)
Fluid Examination (Routine)
(3)
Hematology
(25)
Histopathology
(7)
Hormonal Assay
(24)
Microbiology
(3)
Serology
(17)
Stool
(4)
Urine
(17)
Radio Diagnostic
(79)
CT Scan
(24)
CT Angiography
(6)
Regular CT Scan
(18)
Ultrasound
(38)
Doppler USG
(6)
Pregnancy USG
(12)
Routine USG
(14)
USG Guided
(6)
X-Ray
(17)
Routine Xray
(5)
Special Procedures X-Ray
(12)
177 Lu – Lutetium PSMA therapy for metastatic castrate resistant prostate cancer
₹
150,000.00
*Outsourced to Rohtak Nuclear Medicine Centre
177 Lu - Lutetium PSMA therapy for metastatic castrate resistant prostate cancer quantity
Add to cart
Book Now
Category:
Radionucleide Therapy
Related products
Radioactive Therapy 10mCi
₹
13,000.00
Add to cart
Radioactive Therapy 15mCi
₹
14,000.00
Add to cart
Radioactive Therapy 100mCi
₹
100,000.00
Add to cart
Radioactive Therapy 8mCi
₹
12,200.00
Add to cart